Trials / Completed
CompletedNCT00794768
Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)
Preference Evaluation of Clarinex Tablets vs. Allegra Tablets in Subjects With Symptomatic Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 118 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This was a crossover study designed to see if patients with seasonal allergy symptoms preferred Clarinex® or Allegra®. Patients were randomized to take 7 days of Clarinex or Allegra treatment, followed by a 5 to 28-day washout period (days when no drug is given), followed by 7 days of the opposite treatment. At the end of each 7-day treatment, patients were asked questions to determine which drug, Clarinex or Allegra, the patient prefers more.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | desloratadine 5 mg | Clarinex 5 mg daily x 7 days |
| DRUG | fexofenadine | Allegra 180 mg daily x 7 days |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2003-07-01
- Completion
- 2003-07-01
- First posted
- 2008-11-20
- Last updated
- 2022-02-17
Source: ClinicalTrials.gov record NCT00794768. Inclusion in this directory is not an endorsement.